Case: 12-1523 Document: 43 Page: 1 Filed: 10/15/2012
NOTE: This order is nonprecedential.
Wntteb ~tate~ «ourt of ~peaI~
for tbe jfeberaI «treutt
THE RESEARCH FOUNDATION OF STATE
UNIVERSITY OF NEW YORK,
Plaintiff,
AND
NEW YORK UNIVERSITY,
Plaintiff-Cross Appellant,
AND
GALDERMA LABORATORIES INC.
AND GALDERMA LABORATORIES, L.P.,
Plaintiffs-Cross Appellants,
v.
MYLAN PHARMACEUTICALS INC.,
Defendant-Appellant,
MYLAN PHARMACEUTICALS INC.,
Plaintiff-Appellant,
v.
GALDERMA LABORATORIES INC. AND
GALDERMA LABORATORIES, L.P.,
Defendants-Cross Appellants,
AND
SUPERNUS PHARMACEUTICALS, INC.,
Defendant-Appellee.
Case: 12-1523 Document: 43 Page: 2 Filed: 10/15/2012
RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS 2
2012-1523, -1524, -1555, -1556, -1557
Appeals from the United States District Court for the
District of Delaware in case nos. 09-CV-0184 and 10-CV-
0892, Judge Leonard P. Stark.
THE RESEARCH FOUNDATION OF STATE
UNIVERSITY OF NEW YORK,
Plaintiff,
AND
SUPERNUS PHARMACEUTICALS, INC.,
Plaintiff-Appellee,
AND
NEW YORK UNIVERSITY,
Plaintiff-Cross Appellant,
AND
GALDERMA LABORATORIES INC. AND
GALDERMA LABORATORIES, L.P.,
Plaintiffs-Cross Appellants
v.
IMPAX LABORATORIES, INC.,
Defendant-Appellant.
2012-1545, -1546, -1590, -1591, -1592
Case: 12-1523 Document: 43 Page: 3 Filed: 10/15/2012
3 RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS
Appeals from the United States District Court for the
District of Delaware in case nos. 09-CV-0703 and 11-CV-
0477, Judge Leonard P. Stark.
GALDERMA LABORATORIES INC. AND
GALDERMA LABORATORIES, L.P.,
Plaintiffs-Cross Appellants,
AND
SUPERNUS PHARMACEUTICALS, INC.,
Plaintiff-Appellee,
v.
LUPIN LIMITED AND LUPIN PHARMACEUTICALS,
INC.,
Defendants-Appellants.
2012-1566, -1596
Appeals from the United States District Court for the
District of Delaware in case no. 10-CV-1112, Judge Leo-
nard P. Stark.
THE RESEARCH FOUNDATION OF STATE
UNIVERSITY OF NEW YORK,
Plaintiff,
AND
NEW YORK UNIVERSITY,
Plaintiff-Appellant,
AND
Case: 12-1523 Document: 43 Page: 4 Filed: 10/15/2012
RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS 4
GALDERMA LABORATORIES INC. AND
GALDERMA LABORATORIES, L.P.,
Plaintiffs-Appellants
v.
LUPIN LIMITED AND LUPIN PHARMACEUTICALS,
INC.,
Defendants-Cross Appellants.
2012-1597, -1598, -1599
Appeals from the United States District Court for the
District of Delaware in case no. 09-CV-0483, Judge Leo-
nard P. Stark.
ON MOTION
ORDER
Upon consideration of Galderma Laboratories Inc., et
al.'s unopposed motions to consolidate the above cap-
tioned appeals and set the briefing schedule,
IT Is ORDERED THAT:
(1) The motions are granted. Mylan Pharmaceuticals,
Inc., Impax Laboratories, Inc., Lupin Limited, and Lupin
Pharmaceuticals, Inc.'s principal briefs are due October 1,
2012. Galderma Laboratories Inc., Galderma Laborato-
ries, L.P., Supernus Pharmaceuticals, Inc., and New York
University's principal and response briefs are due No-
vember 13, 2012. Mylan, Impax, and Lupin's re-
Case: 12-1523 Document: 43 Page: 5 Filed: 10/15/2012
5 RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS
sponse/reply briefs are due December 26,2012. Galderma
and New York University's reply briefs are due January
11,2013.
(2) The revised official caption is reflected above.
FOR THE COURT
/s/ Jan Horbaly
Jan Horbaly
Clerk
s26